What Mantra Pharma does

Mantra Pharma is a privately-held Canadian pharmaceutical company founded in 2006 and headquartered in Brossard, Quebec, with a secondary warehouse and offices in Lévis. The company develops and commercializes generic prescription drugs, over-the-counter medications, and Health Canada-approved natural health products (NPN licensed) under a portfolio of proprietary sub-brands: Denta (oral health), mcal (bone health/calcium supplements), Cardiosmile (cardiovascular), Eczederm (skin care), Urederma (dermatology), and the Marque 'M' generic line. Recent product launches include M-METFORMIN 1000mg (January 2025) and an mcal calcium citrate powder SKU (April 2026). The company also operates the Myriad Pharma division, which brokers OTC product placement for external brands into pharmacy retail.

Mantra serves pharmacies, pharmacists, physicians, dentists, and other healthcare professionals across Quebec and Canada, reaching them through a hybrid go-to-market of dedicated field pharmaceutical advisors and medical delegates, a B2B online ordering portal, free professional webinars and continuing education, and the MantrAssistance patient support program. Revenue streams include one-time product sales of generic and OTC/NHP SKUs, representation fees and commissions from agreements such as the official Quebec representation of Dr. Reddy's (announced October 2025) and Myriad Pharma contracts with Laboratoire Modilac and La ligne J'ARRÊTE, and professional services revenue from clinical/organizational consulting for pharmacies on topics including Law 25 compliance and chronic disease management.

In November 2023, Mantra brought Marcan Pharmaceuticals in as a shareholder to support expansion across Canada, and the company is currently led by President Jean François Letarte. The firm has 51-100 employees, no disclosed AI/technology platform, no public funding rounds beyond the Marcan equity event, and no operations outside Quebec/Canada. It is positioning itself in adjacent therapeutic markets including PCOS treatment alongside larger global generic manufacturers.

Name

Mantra Pharma

Legal name

Mantra Pharma

Website

https://groupemantra.ca

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Mantra Pharma is a privately-held Canadian pharmaceutical company that develops and markets generic prescription drugs, OTC medications, and Health Canada-approved natural health products through pharmacy networks across Quebec and Canada, supported by field sales, a B2B portal, and professional services for healthcare professionals.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Generic pharmaceuticals
• Over-the-counter medications
• Natural health products
• Pharmaceutical distribution
• Pharmacy professional services

Headquarters

HQ city

Brossard

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Generic prescription drugs: Mantra Pharma develops and commercializes generic drugs containing the same active ingredients as originator brands. Revenue is generated through the sale of prescription medications to pharmacies and healthcare institutions across Quebec and Canada.
2. Over-the-counter (OTC) and non-prescription products: Sale of OTC medications and natural health products (produits de santé naturels), all approved by Health Canada with NPN (Natural Product Number) designations. Products span brands such as Denta, Eczederm, Urederma, mcal, and Cardiosmile, available both by prescription and over-the-counter.
3. Professional services: Mantra Pharma offers consulting services to pharmacies covering clinical expertise (consultations, chronic disease management programs such as 'Un acte à la fois'), organizational expertise (workflow optimization, pharmacy profitability), and continuing education via webinars and training programs. Three advisory committees (pharmacy owners, salaried pharmacists, and generalist/specialist physicians) inform the service offering.
4. Brand licensing and representation agreements: Mantra Pharma acts as the official Quebec representative for third-party brands including Dr. Reddy's, as well as brokering OTC product placement for external companies through its Myriad Pharma division. Revenue derives from representation fees and commercial commissions.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Mantra Pharma develops, manufactures, and commercializes a portfolio of generic prescription drugs, over-the-counter medications, and Health Canada-approved natural health products (NPN-licensed) sold under its own private-label brands (mcal®, Cardiosmile, Denta, Eczederm, Urederma, and Marque 'M'). The company distributes these products to pharmacies, physicians, dentists, and other healthcare professionals across Quebec and Canada via a B2B online ordering portal and a field sales force of pharmaceutical advisors and medical delegates. It also provides professional consulting, training/webinars, and representation/brokerage services (including acting as Quebec representative for Dr. Reddy's) to pharmacies and consumer health brands.

Product overview

Mantra Pharma is a Canadian pharmaceutical company offering a diversified portfolio of products and services. The core product portfolio includes generic prescription medications (such as M-METFORMIN), over-the-counter drugs, and Health Canada-approved natural health products (NPN licensed). Product offerings are organized under branded sub-brands including mcal® (bone health/calcium supplements), Cardiosmile (cardiovascular/cholesterol management), Denta (oral health), Eczederm (skin care), and Urederma (dermatological care), as well as the Marque 'M' generic line. The company operates through multiple channels including its own branded products and representation agreements (including becoming official representative for Dr. Reddy's products in Quebec). Professional services include clinical and organizational consulting for pharmacies, training programs, and webcasts for healthcare professionals. Myriad Pharma division handles OTC product brokerage and commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• Denta: Oral/dental health expert brand providing products for dry mouth relief, treatment of oral ulcers, and cavity prevention.
• mcal
• Cardiosmile
• Eczederm
• Urederma
• Myriad Pharma

Products and services

• M-METFORMIN 1000mg Generic metformin 1000mg medication for the treatment of diabetes, sold to pharmacies and healthcare professionals as part of Mantra Pharma's affordable generic pharmaceuticals portfolio.
• mcal® Bone Health Brand Private-label bone health brand offering calcium supplements with or without vitamin D in multiple potencies, including a calcium citrate powder format, for pharmacies, healthcare professionals, and consumers.
• Cardiosmile Cardiovascular Health Brand Private-label cardiovascular health brand offering natural cholesterol management products designed to help maintain heart health, available over the counter and promoted to pharmacists, physicians, and consumers.
• Denta Oral Health Brand Private-label oral health brand addressing dry mouth (xérostomie) relief, treatment of mouth ulcers (aphtes buccaux), and cavity prevention, sold through pharmacies and recommended by dental professionals.
• Eczederm Skin Care Brand Private-label skin care brand offering creams to protect skin and relieve minor irritations, including relief for minor eczema itching, sold through pharmacies.
• Urederma Dermatological Care Brand Private-label dermatological/urological skin care brand included in Mantra Pharma's portfolio, sold through pharmacies for skin protection and minor skin condition relief.
• Marque 'M' Generic Prescription Line Private-label brand offering a wide range of generic prescription, over-the-counter, and natural health products under the Marque 'M' identity, sold to pharmacies and healthcare professionals across Canada.
• Myriad Pharma OTC Brokerage Services Brokerage and commercialization services for over-the-counter pharmacy products, providing external consumer health brands with access to Mantra's pharmacy network for product visibility, shelf positioning, and market placement in Canada.
• Professional Clinical Consulting Services Consulting services covering patient consultations and clinical pharmacy practice, including chronic disease management programs such as 'Un acte à la fois', offered to pharmacies and informed by advisory committees of pharmacy owners, salaried pharmacists, and physicians.
• Professional Organizational Consulting Services Consulting services addressing pharmacy workflow organization, work profitability, and operational efficiency, including support for legislative changes affecting the drug circuit, privacy (Quebec Law 25), and authorized professional activities (Quebec Law 5).
• Training, Webinars, and Podcasts (Balados) Free online training programs, webinars, and podcast-style educational content (balados) for healthcare professionals including pharmacists and physicians, with curriculum informed by three advisory committees.

Quantifiable outcome

• North America held 32.56% of the global PCOS treatment market in 2024

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Dr. Reddy'scoreChannel Partner/ Reseller/ Distributor · 22 October 2025Mantra Pharma became the official representative of Dr. Reddy's products in Quebec. This gives Mantra the commercial mandate to represent and distribute Dr. Reddy's pharmaceutical portfolio within the Quebec market, expanding Mantra's prescription drug offering with an established global generic manufacturer.
• Myriad Pharma / Laboratoire ModilacminorChannel Partner/ Reseller/ Distributor · 17 March 2025Myriad Pharma, a division of Mantra Pharma, entered new representation contracts covering Laboratoire Modilac products. Myriad Pharma specializes in OTC brokerage and commercialization, providing pharmacy network access to brands seeking market placement in Canada.
• Myriad Pharma / La ligne J'ARRÊTEminorChannel Partner/ Reseller/ Distributor · 17 March 2025Myriad Pharma, a division of Mantra Pharma, entered representation contracts for La ligne J'ARRÊTE products. This extends Myriad's OTC brand portfolio within its pharmacy network, targeting smoking cessation and lifestyle health categories.
• Marcan PharmaceuticalscoreStrategic or Co-development Partner · 7 November 2023Mantra Pharma increased its ownership stake by bringing Marcan Pharmaceuticals in as a shareholder. The agreement is designed to support Mantra's growth in Quebec and across Canada by expanding product offerings, securing supply chains, and enhancing market share and operational capabilities. Marcan's role as a shareholder indicates a strategic equity and operational partnership.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Dr. Reddy's Laboratories: India-based global generic manufacturer whose Quebec product portfolio Mantra now represents. Comparable as a generic Rx supplier and strategically linked to Mantra via the October 2025 representation mandate.
• Sandoz: Global generic and biosimilar manufacturer, spun off from Novartis in 2023. Relevant incumbent competitor in Canadian generic retail pharmacy channels and as a potential partner or acquirer of regional players like Mantra.
• Teva Pharmaceutical Industries: World's largest generic manufacturer, identified alongside Mantra in the global PCOS treatment competitive landscape. Relevant as the dominant global-scale incumbent whose Canadian pricing and pipeline decisions directly shape Mantra's competitive context.

Direct peers

• Sanis Health: Canadian manufacturer of generic prescription and OTC products distributed through pharmacy networks. Closely comparable private-pharma profile to Mantra with shared focus on affordable generics and Canadian pharmacy channel coverage.
• Laboratoire Riva: Quebec-headquartered Canadian private pharmaceutical company producing generics, OTC, and natural health products. Highly comparable private-Canadian peer with overlapping Quebec pharmacy distribution and Health Canada NPN-anchored product lines.
• Marcan Pharmaceuticals: Canadian pharmaceutical manufacturer and now Mantra's strategic shareholder (since November 2023). Closely aligned private-Canadian generic-pharma profile and a directly cooperative relationship on supply chain and product expansion.
• Pharmascience Inc. Montreal-headquartered Canadian private pharmaceutical company producing generic Rx, OTC, and natural health products. Closest geographic and product overlap with Mantra — both are privately held Canadian pharma marketing generics and branded OTC products through Quebec pharmacy networks.
• JAMP Pharma Group: Canadian generic pharmaceutical manufacturer serving pharmacies and wholesalers nationwide. Comparable product breadth (Rx generics plus OTC and natural health) and a similarly pharmacy-channel go-to-market model.
• Apotex Inc. Canada's largest generic pharmaceutical manufacturer, headquartered in Toronto. Directly comparable to Mantra: develops and markets generic Rx and OTC products through Canadian pharmacy distribution, with a comparable multi-product generic portfolio and similar target channels.

Emerging players

• Jamieson Wellness Inc. Canadian market leader in branded natural health products and vitamins (Health Canada NPN-anchored). Comparable as a competing natural-health brand sold through Canadian pharmacy channels where Mantra's mcal, Cardiosmile, and Denta compete for shelf and recommendation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/mantrapharma
• LinkedInlinkedin.com/company/mantrapharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mantra Pharma